PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 2 filers reported holding PEAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,396 | -87.2% | 126,122 | 0.0% | 0.00% | -88.2% |
| Q4 2022 | $18,780 | -99.9% | 126,122 | 0.0% | 0.02% | +70.0% |
| Q3 2022 | $21,416,000 | +106980.0% | 126,122 | 0.0% | 0.01% | +11.1% |
| Q2 2022 | $20,000 | -80.0% | 126,122 | 0.0% | 0.01% | -86.4% |
| Q1 2022 | $100,000 | -99.9% | 126,122 | 0.0% | 0.07% | -16.5% |
| Q4 2021 | $75,686,000 | – | 126,122 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADVISORY RESEARCH INC | 188,971 | $208 | 0.00% |
| Westchester Capital Management, LLC | 63,181 | $69 | 0.00% |